Date Filed | Type | Description |
08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/01/2023 |
8-K
| Quarterly results |
02/08/2023 |
SC 13G
| Redmile Group, LLC reports a 6.8% stake in AYALA PHARMACEUTICALS, Inc. |
01/30/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
01/30/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Interactive Data |
01/30/2023 |
SC 13G
| Schindel Yair Chaim reports a 12.2% stake in Ayala Pharmaceutics, Inc |
01/25/2023 |
8-K
| Completion of Acquisition or Disposition of Assets, Departure of Directors or Certain Officers; Election of Directors; Appoin... |
01/13/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure Interactive Data |
01/12/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
01/12/2023 |
8-K
| Other Events Interactive Data |
12/13/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
12/12/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
12/12/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
12/08/2022 |
S-4/A
| Form S-4/A - Registration of securities, business combinations: [Amend] |
12/02/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
12/02/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
12/02/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs:
|
"ADVAXIS, INC. CERTIFICATE OF DESIGNATION OF SERIES E PREFERRED STOCK Pursuant to Section 151 of the General Corporation Law of the State of Delaware THE UNDERSIGNED DOES HEREBY CERTIFY, on behalf of Advaxis, Inc., a Delaware corporation , that the following resolution was duly adopted by the board of directors of the Corporation , in accordance with the provisions of Section 151 of the General Corporation Law of the State of Delaware, as amended on November 16, 2022, which resolution provides for the creation of a series of the Corporation’ s Preferred Stock, par value $0.001 per share, which is designated as “Series E Preferred Stock,” with the rights, preferences, privileges and restrictions set forth therein. WHEREAS, the Amended and Restated Certificate of Incorporation of the Corporat...",
"SECURITIES PURCHASE AGREEMENT" |
|
11/29/2022 |
S-4
| Form S-4 - Registration of securities, business combinations: |
10/19/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
10/19/2022 |
8-K
| Quarterly results |
07/01/2022 |
8-K
| Quarterly results |
06/27/2022 |
RW
| Form RW - Registration Withdrawal Request: |
06/24/2022 |
8-K
| Quarterly results |
06/10/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
06/07/2022 |
10-Q
| Quarterly Report for the period ended April 30, 2022 |
06/06/2022 |
8-K
| Quarterly results |
05/24/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
05/19/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
05/12/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
05/12/2022 |
8-K
| Quarterly results |
05/02/2022 |
8-K
| Quarterly results |
04/07/2022 |
8-K
| Other Events Interactive Data |
04/01/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
03/28/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
|